Skip to main content

Table 1 Estimated shared CRISPR spacers in saliva and skin

From: Conservation of streptococcal CRISPRs on human skin and saliva

 

Saliva

Skin

Saliva vs skin

Subject

Percent shareda

p-valueb

Percent shareda

p-valueb

Percent shareda

SGI

     

Subject 1

45.91 ± 1.56

<0.0001

23.97 ± 1.36

0.9945

29.39 ± 1.51

Subject 2

55.64 ± 1.51

<0.0001

27.31 ± 1.41

0.9849

31.78 ± 1.44

Subject 3

23.86 ± 1.37

<0.0001

10.27 ± 0.97

0.1584

8.99 ± 0.89

Subject 4

38.60 ± 1.53

<0.0001

16.05 ± 1.19

0.6741

16.83 ± 1.17

SGII

     

Subject 1

48.13 ± 1.61

<0.0001

28.50 ± 1.40

0.9947

34.07 ± 1.56

Subject 2

50.75 ± 1.55

<0.0001

21.64 ± 1.31

0.2537

20.50 ± 1.25

Subject 3

35.31 ± 1.51

<0.0001

7.64 ± 0.84

0.9827

10.37 ± 0.99

Subject 4

52.52 ± 1.57

<0.0001

25.78 ± 1.39

0.9439

28.95 ± 1.41

  1. aBased on the mean of 10,000 iterations. 1,000 random spacers were sampled per iteration.
  2. bEmpirical p-value based on the fraction of times the estimated percent shared spacers for comparisons within skin or saliva exceeds that between skin and saliva. p-values ≤0.05 are represented in bold.